Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Galderma (6.1% weight): Founded in 1981 but only listed in 2024, Galderma is the largest listed pure-play business focused on dermatology. The business sits...
— Alex Gunz
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Galderma Group AG
No other institutional pitches found for this ticker yet.
More institutional theses from The Heptagon Future Trends Fund
As a dominant player in US and global LNG, Cheniere Energy offers highly predictable revenue with over 95% of its sales contracted through the mid-2030s on 20-year take-or-pay agreements. Historical revenue growth...
Equinix has built an unparalleled global footprint of data centers through substantial capital investment, addressing a rapidly growing 250 billion dollar market. With 95% recurring...
As the pioneer of minimally invasive robotic surgery, Intuitive Surgical boasts a massive global installed base and an highly compelling razor-and-blade business model. Over 80% of...